FindTrial
Sign In

Diagnostic efficacy of new method for identifying pancreatobiliary tumors

To study the role of Liquid Based Cytology (LBC) for diagnosis and characterization of Biliopancreatic tumors compared with standard cytology and on-site evaluation-A non-inferiority trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020249
Enrollment
60
Registered
2019-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K869- Disease of pancreas, unspecified

Interventions

Intervention1: Liquid based cytology: .Liquid-based cytology (LBC), enables cells to be suspended in a monolayer. LBC makes better cytological assessment possible with improved sensitivity and specifi

Sponsors

Institute of Liver and Biliary Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consenting patients (or guardian) undergoing EUS guided sampling of suspected pancreato-biliary tumors

Exclusion criteria

Exclusion criteria: 1) Patients on anti-platelet agents(including aspirin). 2) Patients with deranged coagulation parameters, defined by platelet counts 1.8

Design outcomes

Primary

MeasureTime frame
Sensitivity of LBC for diagnosis of Bilio-pancreatic tumors, compared to cytology, on-site evaluation, and cell-block preparation.Timepoint: 0 hour—

Secondary

MeasureTime frame
Performance characteristics of LBC according to origin/ site of biliopancreatic tumors.Timepoint: 0 hour;Performance characteristics of LBC in relation to size of biliopancreatic tumors (2cm vs. 2cm in long axis).Timepoint: 0 hour—

Countries

India

Contacts

Public ContactDr Satyam Sinha

Institute of Liver and Biliary Sciences

shivsarin@gmail.com01146300000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026